European Journal of Cancer
Volume 39, Issue 13 , Pages 1861-1865 , September 2003

Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas

  • A Spatz

      Affiliations

    • Institut Gustave-Roussy, Villejuif, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-4211-4462; fax: +33-1-4211-5263
    • ,
  • M.G Cook

      Affiliations

    • Royal Surrey County Hospital, Guildford, UK
    • ,
  • D.E Elder

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • M Piepkorn

      Affiliations

    • University of Washington, Seattle, WA, USA
    • ,
  • D.J Ruiter

      Affiliations

    • University Medical Center St-Radboud, Nijmegen, The Netherlands
    • ,
  • R.L Barnhill

      Affiliations

    • The George Washington Medical Center, Washington, DC, USA
    • ,
  • on behalf of the EORTC Melanoma group

Received 29 January 2003 ,Accepted 21 February 2003.

References 

  1. Allen AC, Spitz S. Malignant melanoma. A clinico-pathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6:1–45
  2. Thompkins VN. Cutaneous melanoma (ulceration as a prognostic sign). Cancer. 1953;6:1215–1218
  3. Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA. The prognostic significance of ulceration of cutaneous melanoma. Cancer. 1980;45:3012–3017
  4. Day CL, Lew RA, Harrist TJ. Malignant melanoma prognostic factors 4 (ulceration width). J. Dermatol. Surg. Oncol. 1984;10:23–24
  5. Hanekom GS, Stubbings HM, Johnson CA, Kidson SH. The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is not predictive of metastasis for patients with primary melanoma. Melanoma Res. 1999;9:465–473
  6. Larsen TE, Grude TH. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis. Acta Pathol. Microbiol. Scand. [A]. 1979;87A:131–138
  7. McGovern VJ, Shaw HM, Milton GW, McCarthy WH. Ulceration and prognosis in cutaneous malignant melanoma. Histopathology. 1982;6:399–407
  8. Weidner F, Schroll S, Schonberger A. The influence of lymph node metastasis and ulceration of primary melanoma on germinal centers within draining lymph nodes (a histomorphometric study). Arch. Dermatol. Res. 1982;272:155–161
  9. Balch CM, Buzaid AC, Soong SJ, et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001;19:3635–3648
  10. Balch CM, Soong SJ, Gershenwald JE, et al.  Prognostic factors analysis of 17,600 melanoma patients (validation of the American Joint Committee on Cancer melanoma staging system). J. Clin. Oncol. 2001;19:3622–3634
  11. Corona R, Mele A, Amini M, et al.  Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J. Clin. Oncol. 1996;14:1218–1223
  12. Lock-Andersen J, Hou-Jensen K, Hansen JP, Jensen NK, Sogaard H, Andersen PK. Observer variation in histological classification of cutaneous malignant melanoma. Scand. J. Plast. Reconstr. Surg. Hand Surg. 1995;29:141–148
  13. Heenan PJ, Matz LR, Blackwell JB, et al.  Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology. 1984;8:717–729
  14. Ruiter DJ, Spatz A, van den Oord JJ, Cook MG. Pathologic staging of melanoma. Semin. Oncol. 2002;29:370–381
  15. Ruiter DJ, Spatz A, van den Oord JJ, Cook MG. Microstaging in cutaneous melanoma. J. Pathol. 2001;195:525–529
  16. Cohen A. Comparison of correlated correlations. Stat. Med. 1989;8:1485–1495
  17. Hoang MP, Sahin AA, Ordonez NG, Sneige N. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am. J. Clin. Pathol. 2000;113:852–859
  18. Thompson JR. Estimating equations for kappa statistics. Stat. Med. 2001;20:2895–2906
  19. Tubbs R, Skacel M, Pettay J, et al.  Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma. Am. J. Surg. Pathol. 2002;26:908–913
  20. Eggermont AM, Keilholz U, Autier P, Ruiter DJ, Lehmann F, Lienard D. The EORTC Melanoma Group (a comprehensive melanoma research programme by clinicians and scientists. European Organization for Research and Treatment of Cancer). Eur. J. Cancer. 2002;38(Suppl. 4):S114–S119
  21. Cochran AJ, Elashoff D, Morton DL, Elashoff R. Individualized prognosis for melanoma patients. Hum. Pathol. 2000;31:327–331
  22. Lang PG. Current concepts in the management of patients with melanoma. Am. J. Clin. Dermatol. 2002;3:401–426
  23. Bartoli C, Bono A. Comments on Management of cutaneous melanoma M0 (state of the art and trends, Rossi et al. Eur J Cancer, 1997, 33, 2302–2312). Eur. J. Cancer. 1998;34:1467–1468
  24. Eggermont AM. Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma. Eur. J. Cancer. 1998;34(Suppl. 3):S22–S26
  25. Eggermont AM. The current EORTC Melanoma Cooperative Group adjuvant trial programme on malignant melanoma (prognosis versus efficacy, toxicity and costs). Melanoma Res. 1997;7(Suppl. 2):S127–S131
  26. Buzaid AC, Anderson CM. The changing prognosis of melanoma. Curr. Oncol. Rep. 2000;2:322–328
  27. Cascinelli N, Marubini E, Morabito A, Bufalino R. Prognostic factors for stage I melanoma of the skin (a review). Stat. Med. 1985;4:265–278
  28. Cherpelis BS, Haddad F, Messina J, et al.  Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J. Am. Acad. Dermatol. 2001;44:762–766
  29. Busam KJ. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma. Am. J. Clin. Pathol. 2001;115:743–746

PII: S0959-8049(03)00325-3

doi: 10.1016/S0959-8049(03)00325-3

European Journal of Cancer
Volume 39, Issue 13 , Pages 1861-1865 , September 2003

Article Tools

* Image Usage & Resolution